Dr. Remy Durand is the Chief Business Officer at Alpine Immune Sciences (NASDAQ: ALPN) and brings over 10 years of experience in life sciences business development, investing, management consulting, and research. Since joining ALPN in 2018, Dr. Durand has led multiple business development transactions, including partnerships with AbbVie and Horizon Therapeutics, and helped to raise multiple equity financings from top-tier biotech investors. Prior to Alpine Immune Sciences, Remy was a Vice President on the life sciences investment team at Frazier Healthcare Partners, one of the first dedicated healthcare investment firms. During his time at Frazier, Dr. Durand served as a board observer or director on multiple companies. Earlier in his career, Dr. Durand held roles of increasing responsibility at GE Ventures and L.E.K. Consulting, a premier strategic advisor to the life sciences industry.

Dr. Durand received his Ph.D. in Bioengineering from Stanford University.